Methicillin resistant Staphylococcus aureus infection postoperatory complications and prognosis of patients with lower extremity amputations;Influencia de la presencia de Staphylococcus aureus resistente a la meticilina en las complicaciones postoperatorias y en el pronóstico de los pacientes con amputación de extremidad inferior

Medicina Clinica

Volumn 126, Issue 4, 2006, Pages 129-131

  Del Río Solá, M Lourdes ^a   San Norberto García, Enrique ^a   González Fajardo, José A ^a   Carrera Díaz, Santiago ^a   Gutiérrez Alonso, Vicente ^a   Vaquero Puerta, Carlos ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

Amputation; Methicillin; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT;

AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CLINICAL ARTICLE; DEBRIDEMENT; FEMALE; HUMAN; LEG AMPUTATION; LENGTH OF STAY; LIMB AMPUTATION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; NONHUMAN; POSTOPERATIVE COMPLICATION; PROGNOSIS; STAPHYLOCOCCUS INFECTION; SURGICAL WOUND; TREATMENT INDICATION;

EID: 33644548688     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13084021     Document Type: Article

References (10)

1. National Nosocomial Infection Surveillance Report: data summary from October 1986 through April 1998. Anonymous. Anonymous. Atlanta: Hospital Infection Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention: 1998.
2. Nasim A, Thompson MM, Naylor AR, Bell PR, London NJ. The impact of SARM on vascular surgery. Eur J Vasc Endovasc Surg. 2001;22:211-4.
3. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA. 1995;274:639-44.
4. Menon KV, Whiteley MS, Burden P, Galland RB. Surgical patients with methicilin resistant Staphylococcus aureus infection: an analysis of outcome using P-POSSUM. Jr Coll Surg Edinb. 1999;44:161-3.
5. Álvarez Lerma F, Gasulla Guillermo M, Abad Peruga V, Pueyo Pont MJ, Tarragó Eixarch E. Identificación de los tiempos de riesgo de diseminación de Staphylococcus aureus resistente a meticilina en una unidad de medicina intensiva. Med Clin (Barc). 2004;123:207-10.
6. Grimble SAJ, Magee TR, Galland RB. Methicillin-resistant Staphylococcus aureus in patients undergoing major amputation. Eur J Vasc Endovasc Surg. 2001;22:215-8.
7. Murphy GJ, Pararajasingam R, Nasim A, Dennis MH, Sayers RD. Methicillin resistant Staphylococcus aureus infection in vascular patients. Ann R Coll Surg Engl. 2001;83:158-63.
8. Ayliffe GA, Buckles A, Casewell MW, Cookson BD, Cox RA, Duckworth GJ, et al. Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. J Hosp Infect. 1999;43:315-6.
9. Santini C, Baiocchi P, Serra P. Perioperative antibiotic prophylaxis in vascular surgery. Eur J Vasc Endovasc Surg. 1997;14 Suppl A:13-4.
10. Corbacho MS, Sarria Amigot J, Hernández Navarrete MJ, Muniesca Cuenca P, Jiménez Buñuales MT, Arribas Llorente JL. Cambios en los patrones epidemiológicos de la infección por Staphylococcus aureus resistente a la metilicina en un hospital de tercer nivel. Experiencia de 5 años. Med Clin (Barc). 2000;114:136-8.